What does ORL. DR. PAUL VAN DER VEKEN do?

ORL. DR. PAUL VAN DER VEKEN is a specialist medical practice in Erpe-Mere. Private Limited, started on 11 October 2006, 1 establishment.

What is the address of ORL. DR. PAUL VAN DER VEKEN?

The registered office of ORL. DR. PAUL VAN DER VEKEN is located at Egemstraat 61, 9420 Erpe-Mere.

Is ORL. DR. PAUL VAN DER VEKEN still active?

Yes. According to the CBE (30 September 2026) ORL. DR. PAUL VAN DER VEKEN is active, legal situation “Normale toestand”, started on 11 October 2006.

Is ORL. DR. PAUL VAN DER VEKEN registered on Peppol?

Yes, ORL. DR. PAUL VAN DER VEKEN is registered on the Peppol network with ID 0208:0884156681.

What is the enterprise number of ORL. DR. PAUL VAN DER VEKEN?

The enterprise number of ORL. DR. PAUL VAN DER VEKEN is BE0884156681.

When was ORL. DR. PAUL VAN DER VEKEN founded?

ORL. DR. PAUL VAN DER VEKEN was founded on 11 October 2006.

Who are the directors of ORL. DR. PAUL VAN DER VEKEN?

According to the 2025 annual accounts, the directors of ORL. DR. PAUL VAN DER VEKEN are: Paul VAN DER VEKEN.

Is ORL. DR. PAUL VAN DER VEKEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 October 2006; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ORL. DR. PAUL VAN DER VEKEN make in 2025?

ORL. DR. PAUL VAN DER VEKEN posted a profit after taxes of € 287,823 in financial year 2025.

What is the revenue of ORL. DR. PAUL VAN DER VEKEN?

As a small company, ORL. DR. PAUL VAN DER VEKEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 169,271.

ORL. DR. PAUL VAN DER VEKEN (Private Limited) - Erpe-Mere

Dossier ORL. DR. PAUL VAN DER VEKEN, printed on 30 September 2026 from databakkes.be/en/0884156681/orl-dr-paul-van-der-veken. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ORL. DR. PAUL VAN DER VEKEN from Erpe-Mere, company number BE0884156681, closed financial year 2025 with a result of € 287,823 after tax. For that financial year ORL. DR. PAUL VAN DER VEKEN recorded a gross margin of € 169,271 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € 169,524 to € 287,823. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.

What it is worth Growing

€ 1.9 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 287,823

▲ 70% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78,645

▼ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 248,165 paid out

86 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,492

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,451

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,996

▲ 73% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 279,714 Gross margin 2022: € 279,714 First fiscal year in the series	€ 264,400 Gross margin 2023: € 264,400 ▼ 5% vs 2022 (€ 279,714) Unfavourable step	€ 253,075 Gross margin 2024: € 253,075 ▼ 4% vs 2023 (€ 264,400) Unfavourable step	€ 169,271 Gross margin 2025: € 169,271 ▼ 33% vs 2024 (€ 253,075) Unfavourable step	▼ 33%
Profit after taxes	€ 196,253 Profit after taxes 2022: € 196,253 First fiscal year in the series	€ 228,912 Profit after taxes 2023: € 228,912 ▲ 17% vs 2022 (€ 196,253) Favourable step	€ 169,524 Profit after taxes 2024: € 169,524 ▼ 26% vs 2023 (€ 228,912) Unfavourable step	€ 287,823 Profit after taxes 2025: € 287,823 ▲ 70% vs 2024 (€ 169,524) Favourable step	▲ 70%
Equity	€ 1,481,813 Equity 2022: € 1,481,813 First fiscal year in the series	€ 1,710,725 Equity 2023: € 1,710,725 ▲ 15% vs 2022 (€ 1,481,813) Favourable step	€ 1,880,249 Equity 2024: € 1,880,249 ▲ 10% vs 2023 (€ 1,710,725) Favourable step	€ 1,919,906 Equity 2025: € 1,919,906 ▲ 2% vs 2024 (€ 1,880,249) Favourable step	▲ 2%
Total debts	€ 22,079 Total debts 2022: € 22,079 First fiscal year in the series	€ 42,565 Total debts 2023: € 42,565 ▲ 93% vs 2022 (€ 22,079) Unfavourable step	€ 10,375 Total debts 2024: € 10,375 ▼ 76% vs 2023 (€ 42,565) Favourable step	€ 42,715 Total debts 2025: € 42,715 ▲ € 32,340 vs 2024 (€ 10,375) Unfavourable step	▲ € 32,340
Cash	€ 687,120 Cash 2022: € 687,120 First fiscal year in the series	€ 726,527 Cash 2023: € 726,527 ▲ 6% vs 2022 (€ 687,120) Favourable step	€ 617,566 Cash 2024: € 617,566 ▼ 15% vs 2023 (€ 726,527) Unfavourable step	€ 78,645 Cash 2025: € 78,645 ▼ 87% vs 2024 (€ 617,566) Unfavourable step	▼ 87%
Land & buildings	€ 5,636 Land & buildings 2022: € 5,636 First fiscal year in the series	€ 4,553 Land & buildings 2023: € 4,553 ▼ 19% vs 2022 (€ 5,636) Unchanged	€ 3,470 Land & buildings 2024: € 3,470 ▼ 24% vs 2023 (€ 4,553) Unchanged	€ 2,387 Land & buildings 2025: € 2,387 ▼ 31% vs 2024 (€ 3,470) Unchanged	▼ 31%
Retained profit	€ 1,461,813 Retained profit 2022: € 1,461,813 First fiscal year in the series	€ 1,690,725 Retained profit 2023: € 1,690,725 ▲ 16% vs 2022 (€ 1,461,813) Favourable step	€ 1,860,249 Retained profit 2024: € 1,860,249 ▲ 10% vs 2023 (€ 1,690,725) Favourable step	€ 1,899,906 Retained profit 2025: € 1,899,906 ▲ 2% vs 2024 (€ 1,860,249) Favourable step	▲ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 248,165 Dividend 2025: € 248,165 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,503,892 Balance sheet total 2022: € 1,503,892 First fiscal year in the series	€ 1,753,290 Balance sheet total 2023: € 1,753,290 ▲ 17% vs 2022 (€ 1,503,892) Unchanged	€ 1,890,624 Balance sheet total 2024: € 1,890,624 ▲ 8% vs 2023 (€ 1,753,290) Unchanged	€ 1,962,622 Balance sheet total 2025: € 1,962,622 ▲ 4% vs 2024 (€ 1,890,624) Unchanged	▲ 4%

Key figures of ORL. DR. PAUL VAN DER VEKEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to ORL. DR. PAUL VAN DER VEKEN?

What happened at ORL. DR. PAUL VAN DER VEKEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 31, 2025 New annual accounts for financial year 2025: profit of € 287,823 (▲ 70% vs 2024). Source: NBB ↗
Oct 11, 2006 New establishment in Erpe-Mere. KBO
Oct 11, 2006 Start of the company according to the CBE. KBO
2006 Paul VAN DER VEKEN became a director. NBB

In short

From € 196,253 profit in 2022 to € 287,823 profit in 2025.

Paid € 352,560 in corporate taxes since 2022.

Best year ever: 2025, with € 287,823 profit.

Paid out € 248,165 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at ORL. DR. PAUL VAN DER VEKEN? We notify you, reason included.

Follow ORL. DR. PAUL VAN DER VEKEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Paul VAN DER VEKEN

ORL. DR. PAUL VAN DER VEKEN

Behind ORL. DR. PAUL VAN DER VEKEN is Paul VAN DER VEKEN.

See the full network in the app

Directors

According to the 2025 annual accounts

Paul VAN DER VEKEN

Director

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Egemstraat 61

9420 Erpe-Mere

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0884.156.681
VAT number: BE 0884.156.681
Registered office: Egemstraat 61, 9420 Erpe-Mere
Names & denominations: ORL. DR. PAUL VAN DER VEKEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 October 2006
Peppol: Active · Active since 13 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗